Home Healthcare Biotechnology CAR-T Cell Therapy Market

CAR-T Cell Therapy Market Size, Share & Trends Analysis Report By Product (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta, Others), By Indication (Leukemia, Lymphoma, Multiple Myeloma, Autoimmune Disorders, Others), By End User (Hospitals, Cancer Care Treatment Centres, Academic & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 29, 2026 | Author: Dhanashri B | Format: | Report Code: SR7885DR | Pages: 205
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. CAR-T Cell Therapy Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Abecma
    2. Breyanzi
    3. Kymriah
    4. Tecartus
    5. Yescarta
    6. Others
  2. CAR-T Cell Therapy Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Leukemia
    2. Lymphoma
    3. Multiple Myeloma
    4. Autoimmune Disorders
    5. Others
  3. CAR-T Cell Therapy Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Cancer Care Treatment Centres
    3. Academic & Research Institutes
  4. Regional CAR-T Cell Therapy Market
    1. North America
      1. North America CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      2. North America CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      3. North America CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
      4. U.S. CAR-T Cell Therapy Market
        1. U.S. CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. U.S. CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. U.S. CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      5. Canada CAR-T Cell Therapy Market
        1. Canada CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Canada CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Canada CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
    2. Europe
      1. Europe CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      2. Europe CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      3. Europe CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
      4. U.K. CAR-T Cell Therapy Market
        1. U.K. CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. U.K. CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. U.K. CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      5. Germany CAR-T Cell Therapy Market
        1. Germany CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Germany CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Germany CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      6. France CAR-T Cell Therapy Market
        1. France CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. France CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. France CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      7. Spain CAR-T Cell Therapy Market
        1. Spain CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Spain CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Spain CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      8. Italy CAR-T Cell Therapy Market
        1. Italy CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Italy CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Italy CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      9. Russia CAR-T Cell Therapy Market
        1. Russia CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Russia CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Russia CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      10. Nordic CAR-T Cell Therapy Market
        1. Nordic CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Nordic CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Nordic CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      11. Benelux CAR-T Cell Therapy Market
        1. Benelux CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Benelux CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Benelux CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      12. Rest of Europe CAR-T Cell Therapy Market
        1. Rest of Europe CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Rest of Europe CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Rest of Europe CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
    3. APAC
      1. APAC CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      2. APAC CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      3. APAC CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
      4. China CAR-T Cell Therapy Market
        1. China CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. China CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. China CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      5. Korea CAR-T Cell Therapy Market
        1. Korea CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Korea CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Korea CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      6. Japan CAR-T Cell Therapy Market
        1. Japan CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Japan CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Japan CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      7. India CAR-T Cell Therapy Market
        1. India CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. India CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. India CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      8. Australia CAR-T Cell Therapy Market
        1. Australia CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Australia CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Australia CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      9. Taiwan CAR-T Cell Therapy Market
        1. Taiwan CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Taiwan CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Taiwan CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      10. South East Asia CAR-T Cell Therapy Market
        1. South East Asia CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. South East Asia CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. South East Asia CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      11. Rest of Asia-Pacific CAR-T Cell Therapy Market
        1. Rest of Asia-Pacific CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Rest of Asia-Pacific CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Rest of Asia-Pacific CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      2. Middle East and Africa CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      3. Middle East and Africa CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
      4. UAE CAR-T Cell Therapy Market
        1. UAE CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. UAE CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. UAE CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      5. Turkey CAR-T Cell Therapy Market
        1. Turkey CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Turkey CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Turkey CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      6. Saudi Arabia CAR-T Cell Therapy Market
        1. Saudi Arabia CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Saudi Arabia CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Saudi Arabia CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      7. South Africa CAR-T Cell Therapy Market
        1. South Africa CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. South Africa CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. South Africa CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      8. Egypt CAR-T Cell Therapy Market
        1. Egypt CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Egypt CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Egypt CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      9. Nigeria CAR-T Cell Therapy Market
        1. Nigeria CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Nigeria CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Nigeria CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      10. Rest of MEA CAR-T Cell Therapy Market
        1. Rest of MEA CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Rest of MEA CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Rest of MEA CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
    5. LATAM
      1. LATAM CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      2. LATAM CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      3. LATAM CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
      4. Brazil CAR-T Cell Therapy Market
        1. Brazil CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Brazil CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Brazil CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      5. Mexico CAR-T Cell Therapy Market
        1. Mexico CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Mexico CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Mexico CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      6. Argentina CAR-T Cell Therapy Market
        1. Argentina CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Argentina CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Argentina CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      7. Chile CAR-T Cell Therapy Market
        1. Chile CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Chile CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Chile CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      8. Colombia CAR-T Cell Therapy Market
        1. Colombia CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Colombia CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Colombia CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
      9. Rest of LATAM CAR-T Cell Therapy Market
        1. Rest of LATAM CAR-T Cell Therapy Market By Product 2022-2034 (USD MILLION/ Units)
          1. Abecma
          2. Breyanzi
          3. Kymriah
          4. Tecartus
          5. Yescarta
          6. Others
        2. Rest of LATAM CAR-T Cell Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Leukemia
          2. Lymphoma
          3. Multiple Myeloma
          4. Autoimmune Disorders
          5. Others
        3. Rest of LATAM CAR-T Cell Therapy Market By End User 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Cancer Care Treatment Centres
          3. Academic & Research Institutes
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.